Enhancing Gastroenterology Payer Portal Automation

Klivira delivers robust gastroenterology payer portal automation to streamline prior authorizations for high-volume GI treatments and procedures, minimizing administrative burden.

Revenue cycle leaders and prior authorization coordinators in gastroenterology face unique challenges with high-volume biologics, complex procedures, and varied payer requirements. Manual navigation of diverse payer portals for prior authorizations consumes significant staff time and introduces error, directly impacting patient care access and revenue.

The Unique Prior Authorization Landscape in Gastroenterology

Gastroenterology practices contend with a high volume of prior authorizations, particularly for chronic conditions like Inflammatory Bowel Disease (IBD) requiring biologics, advanced diagnostic imaging, and complex endoscopic procedures. The need for periodic re-authorization for ongoing treatments, coupled with payer-specific step therapy protocols, creates a continuous administrative burden that can delay crucial patient care.

Common PA Triggers in Gastroenterology Workflows

IBD biologics: Humira, Stelara, Skyrizi, Entyvio, and their biosimilars, requiring periodic re-authorization.
Hepatitis C direct-acting antivirals: Epclusa, Mavyret, with genotype and fibrosis stage documentation.
Advanced imaging: MRCP, MR enterography, CT enterography for IBD assessment.
Endoscopic procedures: Capsule endoscopy (CPT 91110), ERCP, EUS for specific indications.
Specialty drugs for functional GI disorders: Viberzi, Motegrity, Linzess, Trulance.
Bariatric surgery and non-routine colonoscopy surveillance.

Overcoming Manual Payer Portal Inefficiencies for GI Prior Authorizations

Many payers, particularly regional plans and specialty benefit managers, still rely on manual web portals for prior authorization submissions, lacking API connectivity like Da Vinci PAS or X12 278. This necessitates staff to manually log in, navigate unique UIs, transcribe patient and clinical data from the EMR, and upload documentation for each individual authorization, leading to significant time expenditure and potential for transcription errors.

Klivira's Approach to Gastroenterology Payer Portal Automation

Klivira implements a sophisticated payer portal automation layer that acts as a bridge for payers without API capabilities. Our headless browser technology and per-payer adapters are specifically configured to handle the nuances of various payer portals, automating login, form submission, and attachment uploads for GI-specific requests. This reduces the manual burden, allowing GI teams to focus on patient care rather than administrative tasks.

Klivira's GI-Specific Automation Capabilities

ACG/AGA-guideline-aware step therapy logic for IBD biologic sequencing.
Automated treatment-status classification from EMR medication history for biologics and Hep C DAAs.
Periodic re-authorization workflow management for chronic IBD biologic treatments.
Medical-vs-pharmacy benefit routing for biologics, adapting to administration mode changes.
Automated submission for advanced imaging and endoscopic procedures, adhering to payer-specific criteria.

Preparing for the Future of Prior Authorization with CMS-0057-F

While payer portal automation addresses current challenges, Klivira's architecture is designed for the future. The platform prioritizes API-based submissions (e.g., Da Vinci PAS, X12 278) when available, and our portal automation layer serves as a transitional solution as impacted payers implement FHIR-based Prior Authorization APIs mandated by CMS-0057-F by January 2027. This ensures your practice is positioned for seamless migration to fully electronic workflows.

Frequently asked questions

How does Klivira handle the varied documentation requirements for IBD biologics across different payers?

Klivira's system is configured with ACG/AGA-guideline-aware logic, enabling it to identify and compile the specific documentation required by each payer for IBD biologics, such as Mayo scores, CDAI, or evidence of prior conventional therapy. This ensures accurate and complete submissions.

Can Klivira's automation address the "medical vs. pharmacy benefit" split for GI biologics?

Yes, Klivira's platform includes medical-vs-pharmacy benefit routing. It intelligently identifies the appropriate benefit channel based on the administration mode (e.g., provider-administered infusion vs. self-administered injection) for biologic agents, ensuring the correct prior authorization pathway is followed.

What happens when a payer portal updates its interface or forms?

Klivira maintains per-payer adapters that are versioned and continuously updated. When a payer modifies their portal, our team updates the corresponding adapter to ensure uninterrupted automation without disrupting active workflows for other payers.

How does Klivira's payer portal automation integrate with our EMR for GI patient data?

Klivira integrates with your EMR via SMART on FHIR or other established channels to automatically extract relevant patient demographics, clinical context, and medication history. This data is then accurately populated into payer portals via headless browser automation, eliminating manual transcription errors.

Does Klivira's system help with periodic re-authorization for chronic GI conditions?

Absolutely. For chronic treatments like IBD biologics, which require periodic re-authorization (typically every 6-12 months), Klivira's platform automates the tracking and submission of re-authorization requests, ensuring continuous coverage and reducing the risk of treatment delays.

What if a payer implements a new API for prior authorizations?

Klivira's routing engine actively monitors for new API capabilities, such as Da Vinci PAS or X12 278. When a payer launches an API, Klivira automatically shifts from portal automation to the more efficient API path, future-proofing your prior authorization process.